Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Mallinckrodt
Deloitte
Healthtrust
UBS
Colorcon
Cantor Fitzgerald
Fish and Richardson
Queensland Health

Generated: June 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040624

« Back to Dashboard

NDA 040624 describes METHSCOPOLAMINE BROMIDE, which is a drug marketed by Bayshore Pharms Llc, Breckenridge Pharm, Pvt Form, and Vintage Pharms, and is included in four NDAs. It is available from five suppliers. Additional details are available on the METHSCOPOLAMINE BROMIDE profile page.

The generic ingredient in METHSCOPOLAMINE BROMIDE is methscopolamine bromide. There are seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the methscopolamine bromide profile page.
Summary for 040624
Tradename:METHSCOPOLAMINE BROMIDE
Applicant:Vintage Pharms
Ingredient:methscopolamine bromide
Patents:0
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 040624
Mechanism of ActionCholinergic Antagonists
Suppliers and Packaging for NDA: 040624
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METHSCOPOLAMINE BROMIDE methscopolamine bromide TABLET;ORAL 040624 ANDA Golden State Medical Supply, Inc. 60429-251 E 60429-251-01
METHSCOPOLAMINE BROMIDE methscopolamine bromide TABLET;ORAL 040624 ANDA Golden State Medical Supply, Inc. 60429-251 E 60429-251-60

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2.5MG
Approval Date:Dec 28, 2006TE:AARLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Dec 28, 2006TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Julphar
Queensland Health
Medtronic
US Department of Justice
Colorcon
Deloitte
Daiichi Sankyo
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.